scholarly article | Q13442814 |
P819 | ADS bibcode | 2000PNAS...9712272O |
P356 | DOI | 10.1073/PNAS.220414397 |
P932 | PMC publication ID | 17331 |
P698 | PubMed publication ID | 11027316 |
P5875 | ResearchGate publication ID | 12297689 |
P50 | author | Josef Penninger | Q1674391 |
David Siderovski | Q21062222 | ||
Pamela Ohashi | Q56891473 | ||
P2093 | author name string | B E Snow | |
T Sasaki | |||
A Wakeham | |||
I Q Whishaw | |||
C A Barnes | |||
D Bai | |||
J C Roder | |||
G Matsumoto | |||
F P Houston | |||
S Mariathasan | |||
A J Oliveira-Dos-Santos | |||
P2860 | cites work | The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulation | Q77844749 |
GTPase Activating Specificity of RGS12 and Binding Specificity of an Alternatively Spliced PDZ (PSD-95/Dlg/ZO-1) Domain | Q24311627 | ||
RGS2/G0S8 is a selective inhibitor of Gqα function | Q24648296 | ||
Sst2, a negative regulator of pheromone signaling in the yeast Saccharomyces cerevisiae: expression, localization, and genetic interaction and physical association with Gpa1 (the G-protein alpha subunit). | Q27931672 | ||
Regulators of G protein signaling exhibit distinct patterns of gene expression and target G protein specificity in human lymphocytes | Q28138524 | ||
The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation | Q28244304 | ||
EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins | Q28272431 | ||
GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits | Q28286818 | ||
RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits | Q28287870 | ||
RGS10 is a selective activator of G alpha i GTPase activity | Q28287882 | ||
G proteins: transducers of receptor-generated signals | Q29547519 | ||
Role of regulator of G protein signaling in desensitization of the glucose-dependent insulinotropic peptide receptor | Q31988110 | ||
Making more synapses: a way to store information? | Q33651849 | ||
Whither goest the RGS proteins? | Q33750131 | ||
A human gene encoding a putative basic helix-loop-helix phosphoprotein whose mRNA increases rapidly in cycloheximide-treated blood mononuclear cells | Q34340914 | ||
Comparison of mRNA expression of two regulators of G-protein signaling, RGS1/BL34/1R20 and RGS2/G0S8, in cultured human blood mononuclear cells. | Q34427921 | ||
Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity | Q39116365 | ||
Isolation and genetic analysis of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by a factor and alpha factor pheromones | Q40679118 | ||
Emotion: systems, cells, synaptic plasticity | Q41000800 | ||
Mammalian RGS Proteins: Barbarians at the Gate | Q41682826 | ||
Heterotrimeric G Protein Signaling: Roles in Immune Function and Fine-Tuning by RGS Proteins | Q41700415 | ||
Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. | Q41719683 | ||
The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling | Q42462089 | ||
Acquisition of a spatial conditioned place preference is impaired by amygdala lesions and improved by fornix lesions | Q48264687 | ||
Regulators of G Protein Signaling: Rapid Changes in mRNA Abundance in Response to Amphetamine | Q48478026 | ||
Src Activation in the Induction of Long-Term Potentiation in CA1 Hippocampal Neurons | Q48511336 | ||
Expression of RGS2 alters the coupling of metabotropic glutamate receptor 1a to M-type K+ and N-type Ca2+ channels | Q77407731 | ||
An evolutionary approach to behavioral pharmacology: using drugs to understand proximate and ultimate mechanisms of different forms of aggression in mice | Q77780612 | ||
P2507 | corrigendum / erratum | Correction for Oliveira-dos-Santos et al., Regulation of T cell activation, anxiety, and male aggression by RGS2 | Q99593652 |
P433 | issue | 22 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | T cell activation | Q14863969 |
P304 | page(s) | 12272-12277 | |
P577 | publication date | 2000-10-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Regulation of T cell activation, anxiety, and male aggression by RGS2 | |
P478 | volume | 97 |
Q57298374 | A bronchoprotective role for in a murine model of lipopolysaccharide-induced airways inflammation |
Q37388394 | A specific gene expression program triggered by Gram-positive bacteria in the cytosol |
Q48676886 | A switch in G protein coupling for type 1 corticotropin-releasing factor receptors promotes excitability in epileptic brains |
Q40077917 | ATF3 negatively regulates cellular antiviral signaling and autophagy in the absence of type I interferons |
Q24633760 | Activity-regulated genes as mediators of neural circuit plasticity |
Q28547149 | Adenosine Receptors Differentially Regulate the Expression of Regulators of G-Protein Signalling (RGS) 2, 3 and 4 in Astrocyte-Like Cells |
Q30481903 | Aggression and anxiety: social context and neurobiological links |
Q38458914 | Aggression in non-human vertebrates: Genetic mechanisms and molecular pathways. |
Q34420653 | Aggressive behavioral phenotypes in mice |
Q35864203 | Analyses of RGS protein control of agonist-evoked Ca2+ signaling |
Q39764882 | Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer |
Q28582977 | Analysis of regulator of G-protein signaling-2 (RGS-2) expression and function in osteoblastic cells |
Q50645611 | Animal models of human anxiety disorders: reappraisal from a developmental psychopathology vantage point |
Q33686889 | Anti-aggressive effects of neuropeptide S independent of anxiolysis in male rats |
Q36847120 | Anxiety genetics - findings from cross-species genome-wide approaches. |
Q48942767 | Association analysis of Rgs7 variants with panic disorder |
Q80866629 | Association of RGS2 gene polymorphisms with suicide and increased RGS2 immunoreactivity in the postmortem brain of suicide victims |
Q44964445 | Association of RGS2 variants with panic disorder in a Japanese population |
Q30445754 | Behavioral and pharmacogenetics of aggressive behavior. |
Q30724363 | Biological insights into TCRgammadelta+ and TCRalphabeta+ intraepithelial lymphocytes provided by serial analysis of gene expression (SAGE). |
Q30453470 | Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression |
Q34403957 | Bridging with GAPs: receptor communication through RGS proteins |
Q37040871 | Bringing a developmental perspective to anxiety genetics |
Q36837317 | Candidate genes for panic disorder: insight from human and mouse genetic studies. |
Q36557763 | Chemoattractant receptor signaling and the control of lymphocyte migration. |
Q40828336 | Chronic cold exposure increases RGS7 expression and decreases alpha(2)-autoreceptor-mediated inhibition of noradrenergic locus coeruleus neurons |
Q27315216 | Coronin 1 regulates cognition and behavior through modulation of cAMP/protein kinase A signaling |
Q28236836 | Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation |
Q36852562 | Digoxin-Mediated Upregulation of RGS2 Protein Protects against Cardiac Injury. |
Q34917978 | Early Phase of Plasticity-Related Gene Regulation and SRF Dependent Transcription in the Hippocampus |
Q39449435 | Elevated expression of RGS19 impairs the responsiveness of stress-activated protein kinases to serum |
Q44264730 | Endogenous RGS proteins facilitate dopamine D(2S) receptor coupling to G(alphao) proteins and Ca2+ responses in CHO-K1 cells |
Q35163061 | Epigenetic repression of regulator of G‐protein signaling 2 promotes androgen‐independent prostate cancer cell growth |
Q35016294 | Evidence for enhanced M3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2-deficient mouse |
Q43925284 | Expression of RGS2, RGS4 and RGS7 in the developing postnatal brain |
Q30176404 | FBXO44-Mediated Degradation of RGS2 Protein Uniquely Depends on a Cullin 4B/DDB1 Complex. |
Q44877054 | Female mimicry by sneaker males has a transcriptomic signature in both the brain and gonad in a sex changing fish |
Q91775826 | Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia |
Q37775218 | GABAB receptors and depression. Current status. |
Q42437001 | Gene array and protein expression profiles suggest post-transcriptional regulation during CD8+ T cell differentiation |
Q36498074 | Generation and characterization of rgs5 mutant mice |
Q57178844 | Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease |
Q50989320 | Genetic dissection of a behavioral quantitative trait locus shows that Rgs2 modulates anxiety in mice. |
Q48438578 | Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G-protein signalling (Rgs) transcripts |
Q38433112 | Genomic Analysis of Genotype-by-Social Environment Interaction for Drosophila melanogaster Aggressive Behavior |
Q46084582 | Hippocampal long-term potentiation is enhanced in urethane-anesthetized RGS2 knockout mice |
Q34177503 | Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice |
Q28211957 | Identification of RGS2 and type V adenylyl cyclase interaction sites |
Q33324833 | Identification of dysregulated genes in lymphocytes from children with Down syndrome. |
Q28348827 | Identification of genes expressed in the amygdala during the formation of fear memory |
Q43875650 | Identification of quantitative trait Loci that affect aggressive behavior in mice. |
Q42873285 | Impact of RGS2 deficiency on the therapeutic effect of telmisartan in angiotensin II-induced aortic aneurysm |
Q47635917 | Increased fear learning, spatial learning as well as neophobia in Rgs2-/- mice. |
Q37705725 | Influence of RGS2 on sertraline treatment for social anxiety disorder |
Q36087237 | Inhibition of the Binding between RGS2 and β-Tubulin Interferes with Spindle Formation and Chromosome Segregation during Mouse Oocyte Maturation In Vitro |
Q44000247 | Interferon beta-1a counteracts effects of activation on the expression of G-protein-coupled receptor kinases 2 and 3, beta-arrestin-1, and regulators of G-protein signalling 2 and 16 in human mononuclear leukocytes. |
Q90944128 | Interplay between RGS2 and childhood adversities in predicting anxiety and depressive disorders: Findings from a general population sample |
Q35842514 | Is RGS-2 a new drug development target in cardiovascular disease? |
Q28190356 | Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome |
Q41108608 | MicroRNA hsa-miR-4717-5p regulates RGS2 and may be a risk factor for anxiety-related traits |
Q33858253 | Modulating Oxidative Stress Relieves Stress-Induced Behavioral and Cognitive Impairments in Rats |
Q28206684 | Molecular basis of aggression |
Q35025111 | Novel role of RGS2 in regulation of antioxidant homeostasis in neuronal cells |
Q37726361 | Nuclear trafficking of regulator of G protein signaling proteins and their roles in the nucleus. |
Q43193872 | Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells |
Q33609711 | Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR). |
Q77368792 | Profile of RGS expression in single rat atrial myocytes |
Q36255835 | Protective Roles for RGS2 in a Mouse Model of House Dust Mite-Induced Airway Inflammation. |
Q35995502 | Protein expression pattern in response to ionizing radiation in MCF-7 human breast cancer cells |
Q47703780 | Proteolytic degradation of regulator of G protein signaling 2 facilitates temporal regulation of Gq/11 signaling and vascular contraction |
Q36301542 | R4 RGS proteins: regulation of G-protein signaling and beyond |
Q38644453 | R4 Regulator of G Protein Signaling (RGS) Proteins in Inflammation and Immunity |
Q35906057 | RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives |
Q35864233 | RGS-insensitive G-protein mutations to study the role of endogenous RGS proteins |
Q37219296 | RGS13 controls g protein-coupled receptor-evoked responses of human mast cells |
Q24533459 | RGS18 is a myeloerythroid lineage-specific regulator of G-protein-signalling molecule highly expressed in megakaryocytes |
Q28564356 | RGS2 and RGS4 modulate melatonin-induced potentiation of glycine currents in rat retinal ganglion cells |
Q37153202 | RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults |
Q28362831 | RGS2 blocks slow muscarinic inhibition of N-type Ca(2+) channels reconstituted in a human cell line |
Q82781856 | RGS2 deficiency in mice does not affect platelet thrombus formation at sites of vascular injury |
Q90841044 | RGS2 drives male aggression in mice via the serotonergic system |
Q47736411 | RGS2 ggenetic variation: association analysis with panic disorder and dimensional as well as intermediate phenotypes of anxiety |
Q42827782 | RGS2 promotes adipocyte differentiation in the presence of ligand for peroxisome proliferator-activated receptor gamma |
Q36597655 | RGS2 squelches vascular Gi/o and Gq signaling to modulate myogenic tone and promote uterine blood flow |
Q45109515 | RGS2-mediated regulation of Gqalpha |
Q35067290 | RGS2: a "turn-off" in hypertension |
Q37342199 | RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation |
Q28570437 | Receptor-selective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular smooth muscle cells |
Q44000320 | Reduced anxiety-- and depression-like behaviors in Emx1 homozygous mutant mice |
Q37204048 | Regulation of G-protein-coupled signaling pathways in allergic inflammation |
Q35700543 | Regulation of Renal Hemodynamics and Function by RGS2. |
Q37726377 | Regulation of immune function by G protein-coupled receptors, trimeric G proteins, and RGS proteins. |
Q64081493 | Regulator of G Protein Signaling 2 Facilitates Uterine Artery Adaptation During Pregnancy in Mice |
Q30512752 | Regulator of G protein signaling 2 deficiency causes endothelial dysfunction and impaired endothelium-derived hyperpolarizing factor-mediated relaxation by dysregulating Gi/o signaling |
Q38765048 | Regulator of G protein signaling 2 is a key regulator of pancreatic β-cell mass and function |
Q28594677 | Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice |
Q82437098 | Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells |
Q37657112 | Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT(1A) receptor-adenylyl cyclase axis. |
Q24299443 | Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure |
Q36465333 | Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers |
Q35523846 | Regulators of G Protein Signaling (RGS) Proteins as Drug Targets: Modulating G-Protein-Coupled Receptor (GPCR) Signal Transduction |
Q35015775 | Regulators of G protein signaling (RGS proteins): novel central nervous system drug targets |
Q88493279 | Regulators of G protein signaling in cardiovascular function during pregnancy |
Q37726382 | Regulators of G protein signaling in neuropsychiatric disorders |
Q37778514 | Regulators of G protein signaling proteins as targets for drug discovery. |
Q38036343 | Regulators of G protein signaling: role in hematopoiesis, megakaryopoiesis and platelet function |
Q34198530 | Regulators of G-Protein Signaling and Their Gα Substrates: Promises and Challenges in Their Use as Drug Discovery Targets |
Q34139169 | Regulators of G-protein signalling as new central nervous system drug targets. |
Q50603405 | Relationship between Rgs2 gene expression level and anxiety and depression-like behaviour in a mutant mouse model: serotonergic involvement |
Q34456993 | Renal Actions of RGS2 Control Blood Pressure |
Q47384171 | Resistance to age-related, normal body weight gain in RGS2 deficient mice |
Q50936324 | Rgs 2 gene polymorphisms as modulators of anxiety in humans? |
Q33873408 | Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1. |
Q42220183 | Role of Cholinergic Innervation and RGS2 in Atrial Arrhythmia. |
Q37665104 | Role of regulator of G protein signaling proteins in bone. |
Q36502948 | Roles for Regulator of G Protein Signaling Proteins in Synaptic Signaling and Plasticity |
Q29619896 | Seven-transmembrane receptors |
Q40442171 | Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors |
Q64116233 | Stiff Substrates Enhance Endothelial Oxidative Stress in Response to Protein Kinase C Activation |
Q27655668 | Structural Determinants of G-protein Subunit Selectivity by Regulator of G-protein Signaling 2 (RGS2) |
Q27650447 | Structural diversity in the RGS domain and its interaction with heterotrimeric G protein -subunits |
Q40696990 | Structure, chromosomal localization and expression of the mouse regulator of G-protein signaling10 gene (mRGS10). |
Q55000833 | T Cell Calcium Signaling Regulation by the Co-Receptor CD5. |
Q28544733 | Tempol treatment reduces anxiety-like behaviors induced by multiple anxiogenic drugs in rats |
Q28582867 | Temporal and spatial patterns of ovarian gene transcription following an ovulatory dose of gonadotropin in the rat |
Q33424478 | Temporally regulated traffic of HuR and its associated ARE-containing mRNAs from the chromatoid body to polysomes during mouse spermatogenesis |
Q33687812 | Tetrahydrobiopterin in cardiovascular health and disease |
Q24810130 | The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits |
Q59329199 | The Role of G-proteins and G-protein Regulating Proteins in Depressive Disorders |
Q30474232 | The clinical implications of mouse models of enhanced anxiety. |
Q33686078 | The function of activity-regulated genes in the nervous system. |
Q28242051 | The genetic basis of emotional behaviour in mice |
Q46259086 | The heterotrimeric G-protein alpha-subunit Galphaq regulates TCR-mediated immune responses through an Lck-dependent pathway |
Q38806373 | The impact of RGS and other G-protein regulatory proteins on Gαi-mediated signaling in immunity |
Q35202929 | The neurobiology and control of anxious states |
Q38096880 | The regulating function of heterotrimeric G proteins in the immune system |
Q27324836 | The role of inositol 1,4,5-trisphosphate 3-kinase A in regulating emotional behavior and amygdala function |
Q39208385 | Transcriptome analysis of genes and gene networks involved in aggressive behavior in mouse and zebrafish |
Q48657166 | Two new behavioral QTLs, Emo4 and Reb1, map to mouse Chromosome 1: Congenic strains and candidate gene identification studies |
Q42500829 | Up-regulation of endogenous RGS2 mediates cross-desensitization between Gs and Gq signaling in osteoblasts. |
Q37196021 | Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis |
Q33864888 | Upregulation of regulator of G-protein signaling 2 in the sclera of a form deprivation myopic animal model |
Q48507799 | Uterine Foxl2 regulates the adherence of the Trophectoderm cells to the endometrial epithelium |
Q37328251 | Variant in RGS2 moderates posttraumatic stress symptoms following potentially traumatic event exposure |
Q44710807 | Vision: the need for speed |
Q35621371 | β2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids |
Search more.